Bio Plus Co., Ltd

₩2,935As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:099430Healthcare
Country South Korea
PE (Fwd) •••
TSR 5Y CAGR (16.90%)
Div yield 2.38%
ROE 10.65%
Medical Devices
Beta (5Y) 0.56
PE TTM 18.78
TSR TTM (52.37%)
Mkt cap ₩180.6B
ROIC 7.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,096
5.47%
(96.25%)
Hold 11|11|5|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
64.43
62.41
67.30
68.54
31.58%
22.80%
20.77%
17.96%
Revenue₩B
11.50
11.81
12.18
12.38
7.54%
6.89%
13.61%
13.33%
Peers (US$133.2M)
Cap (US$)
PE
160.3M
—
142.4M
7.418x
128.4M
—
133.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.281
0.979
0.732
EBIT/Intx
0.146
0.462
0.348
Own earn%
21.54
29.15
31.21
Sh yield%
9.05
31.03
30.07
Owners
Insiders/Inst%
1.17
86.13
Short interest%
2.92
SBC / revenue%
1.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
4–14
$1 testx
0.0
Incr. ROIC%
6